CompoAtlas

BIOSILK ch-OSA Forte

Natural health product licensed in Canada

Other names
BIOSILK ch-OSA
Licence holder
Provita Nutrition and Health Inc.
NPN or DIN-HM
80074467
Status
Active licence
Licence date
15 December 2016
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Lysine

Source : Monochlorhydrate de L-lysine

100 milligrammeNot calculated
Biotine

Source : Biotine

250 microgrammesNot calculated
Silicium

Source : Choline-stabilised orthosilicic acid

6 milligrammeNot calculated
2-hydroxy-N,N,N-triméthyléthanaminium

Source : Chlorure de choline

120 milligrammeNot calculated
Reynoutria multiflora

Source : Tubercule

100 milligrammeNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Hypromellose, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to maintain healthy hair, nails and skin. Helps in collagen formation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80074467

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line